Loading company…
Pharmolix develops AI models and conversational tools for biopharmaceutical research and drug development.
Founded in 2023, Pharmolix develops large models and tools for biopharmaceutical research and drug development. Its ChatDD assistant supports natural-language interaction and is intended for tasks including target discovery, molecular design, clinical trial design and drug repositioning. The company was incubated by Tsinghua University's Academy of Intelligent Industry Research and is based in China. In August 2024, it raised CNY 100 million in angel funding to develop ChatDD and a biomedical multimodal model.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in